Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

References for PMC Articles for PubMed (Select 20536361)

1.
2.

Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects.

Radosević K, Rodriguez A, Lemckert A, Goudsmit J.

Expert Rev Vaccines. 2009 May;8(5):577-92. doi: 10.1586/erv.09.14. Review.

PMID:
19397415
3.

A recombinant DNA and vaccinia virus prime-boost regimen induces potent long-term T-cell responses to HCV in BALB/c mice.

Deng Y, Zhang K, Tan W, Wang Y, Chen H, Wu X, Ruan L.

Vaccine. 2009 Mar 26;27(15):2085-8. doi: 10.1016/j.vaccine.2009.02.003. Epub 2009 Feb 12.

PMID:
19356609
4.

A protective role for dengue virus-specific CD8+ T cells.

Yauch LE, Zellweger RM, Kotturi MF, Qutubuddin A, Sidney J, Peters B, Prestwood TR, Sette A, Shresta S.

J Immunol. 2009 Apr 15;182(8):4865-73. doi: 10.4049/jimmunol.0801974.

5.

Evaluation of interferences between dengue vaccine serotypes in a monkey model.

Guy B, Barban V, Mantel N, Aguirre M, Gulia S, Pontvianne J, Jourdier TM, Ramirez L, Gregoire V, Charnay C, Burdin N, Dumas R, Lang J.

Am J Trop Med Hyg. 2009 Feb;80(2):302-11.

6.

T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity.

Stone JD, Chervin AS, Kranz DM.

Immunology. 2009 Feb;126(2):165-76. doi: 10.1111/j.1365-2567.2008.03015.x. Review.

7.

Scientific consultation on cell mediated immunity (CMI) in dengue and dengue vaccine development.

Thomas SJ, Hombach J, Barrett A.

Vaccine. 2009 Jan 14;27(3):355-68. doi: 10.1016/j.vaccine.2008.10.086. Epub 2008 Nov 18. Review.

PMID:
19022321
8.

Cross-reactive memory CD8(+) T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner.

Beaumier CM, Mathew A, Bashyam HS, Rothman AL.

J Infect Dis. 2008 Feb 15;197(4):608-17. doi: 10.1086/526790.

10.
11.

Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection.

Brien JD, Uhrlaub JL, Nikolich-Zugich J.

Eur J Immunol. 2007 Jul;37(7):1855-63.

PMID:
17559175
12.

Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis.

Purtha WE, Myers N, Mitaksov V, Sitati E, Connolly J, Fremont DH, Hansen TH, Diamond MS.

Eur J Immunol. 2007 Jul;37(7):1845-54.

PMID:
17559174
13.

Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.

Guirakhoo F, Kitchener S, Morrison D, Forrat R, McCarthy K, Nichols R, Yoksan S, Duan X, Ermak TH, Kanesa-Thasan N, Bedford P, Lang J, Quentin-Millet MJ, Monath TP.

Hum Vaccin. 2006 Mar-Apr;2(2):60-7. Epub 2006 Mar 15.

PMID:
17012873
14.

Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity.

Selin LK, Brehm MA, Naumov YN, Cornberg M, Kim SK, Clute SC, Welsh RM.

Immunol Rev. 2006 Jun;211:164-81. Review.

PMID:
16824126
15.

Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination.

Masopust D, Ha SJ, Vezys V, Ahmed R.

J Immunol. 2006 Jul 15;177(2):831-9.

16.

A live, attenuated recombinant West Nile virus vaccine.

Monath TP, Liu J, Kanesa-Thasan N, Myers GA, Nichols R, Deary A, McCarthy K, Johnson C, Ermak T, Shin S, Arroyo J, Guirakhoo F, Kennedy JS, Ennis FA, Green S, Bedford P.

Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6694-9. Epub 2006 Apr 14. Erratum in: Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10823.

17.

Triaryl pyrazoline compound inhibits flavivirus RNA replication.

Puig-Basagoiti F, Tilgner M, Forshey BM, Philpott SM, Espina NG, Wentworth DE, Goebel SJ, Masters PS, Falgout B, Ren P, Ferguson DM, Shi PY.

Antimicrob Agents Chemother. 2006 Apr;50(4):1320-9.

18.

T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?

Mongkolsapaya J, Duangchinda T, Dejnirattisai W, Vasanawathana S, Avirutnan P, Jairungsri A, Khemnu N, Tangthawornchaikul N, Chotiyarnwong P, Sae-Jang K, Koch M, Jones Y, McMichael A, Xu X, Malasit P, Screaton G.

J Immunol. 2006 Mar 15;176(6):3821-9.

20.

Sculpting the immunological response to dengue fever by polytopic vaccination.

Zhou H, Deem MW.

Vaccine. 2006 Mar 24;24(14):2451-9. Epub 2005 Dec 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk